596 related articles for article (PubMed ID: 11402628)
1. The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus.
Kudolo GB
J Clin Pharmacol; 2001 Jun; 41(6):600-11. PubMed ID: 11402628
[TBL] [Abstract][Full Text] [Related]
2. The effect of 3-month ingestion of Ginkgo biloba extract on pancreatic beta-cell function in response to glucose loading in normal glucose tolerant individuals.
Kudolo GB
J Clin Pharmacol; 2000 Jun; 40(6):647-54. PubMed ID: 10868316
[TBL] [Abstract][Full Text] [Related]
3. The effect of the ingestion of Ginkgo biloba extract (EGb 761) on the pharmacokinetics of metformin in non-diabetic and type 2 diabetic subjects--a double blind placebo-controlled, crossover study.
Kudolo GB; Wang W; Javors M; Blodgett J
Clin Nutr; 2006 Aug; 25(4):606-16. PubMed ID: 16698134
[TBL] [Abstract][Full Text] [Related]
4. Extract of Ginkgo Biloba Ameliorates Streptozotocin-Induced Type 1 Diabetes Mellitus and High-Fat Diet-Induced Type 2 Diabetes Mellitus in Mice.
Rhee KJ; Lee CG; Kim SW; Gim DH; Kim HC; Jung BD
Int J Med Sci; 2015; 12(12):987-94. PubMed ID: 26664261
[TBL] [Abstract][Full Text] [Related]
5. Short-term ingestion of Ginkgo biloba extract does not alter whole body insulin sensitivity in non-diabetic, pre-diabetic or type 2 diabetic subjects--a randomized double-blind placebo-controlled crossover study.
Kudolo GB; Wang W; Elrod R; Barrientos J; Haase A; Blodgett J
Clin Nutr; 2006 Feb; 25(1):123-34. PubMed ID: 16293352
[TBL] [Abstract][Full Text] [Related]
6. Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and Type 2 diabetic subjects.
Kudolo GB; Dorsey S; Blodgett J
Thromb Res; 2002 Nov; 108(2-3):151-60. PubMed ID: 12590952
[TBL] [Abstract][Full Text] [Related]
7. Short-term oral ingestion of Ginkgo biloba extract (EGb 761) reduces malondialdehyde levels in washed platelets of type 2 diabetic subjects.
Kudolo GB; Delaney D; Blodgett J
Diabetes Res Clin Pract; 2005 Apr; 68(1):29-38. PubMed ID: 15811563
[TBL] [Abstract][Full Text] [Related]
8.
Zambrana S; Lundqvist LCE; Mamani O; Catrina SB; Gonzales E; Östenson CG
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037028
[No Abstract] [Full Text] [Related]
9. Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes.
Miyazaki Y; Matsuda M; DeFronzo RA
Diabetes Care; 2002 Mar; 25(3):517-23. PubMed ID: 11874940
[TBL] [Abstract][Full Text] [Related]
10. EGb 761: ginkgo biloba extract, Ginkor.
Drugs R D; 2003; 4(3):188-93. PubMed ID: 12757407
[TBL] [Abstract][Full Text] [Related]
11. Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM.
Berkowitz K; Peters R; Kjos SL; Goico J; Marroquin A; Dunn ME; Xiang A; Azen S; Buchanan TA
Diabetes; 1996 Nov; 45(11):1572-9. PubMed ID: 8866563
[TBL] [Abstract][Full Text] [Related]
12. Age-related alteration of pancreatic beta-cell function. Increased proinsulin and proinsulin-to-insulin molar ratio in elderly, but not in obese, subjects without glucose intolerance.
Shimizu M; Kawazu S; Tomono S; Ohno T; Utsugi T; Kato N; Ishi C; Ito Y; Murata K
Diabetes Care; 1996 Jan; 19(1):8-11. PubMed ID: 8720525
[TBL] [Abstract][Full Text] [Related]
13. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.
Chen KW; Boyko EJ; Bergstrom RW; Leonetti DL; Newell-Morris L; Wahl PW; Fujimoto WY
Diabetes Care; 1995 Jun; 18(6):747-53. PubMed ID: 7555498
[TBL] [Abstract][Full Text] [Related]
14. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
[TBL] [Abstract][Full Text] [Related]
15. Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects.
Schuster DP; Osei K; Zipf WB
Metabolism; 1996 Dec; 45(12):1514-20. PubMed ID: 8969285
[TBL] [Abstract][Full Text] [Related]
16. Short- and long-term gliclazide effects on pancreatic islet cell function and hepatic insulin extraction in non-insulin-dependent diabetes mellitus.
Wajchenberg BL; Santomauro AT; Giannella-Neto D; Borghi VC; Porrelli RN
Diabetes Res Clin Pract; 1992 Aug; 17(2):89-97. PubMed ID: 1425152
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of
Aziz TA; Hussain SA; Mahwi TO; Ahmed ZA; Rahman HS; Rasedee A
Drug Des Devel Ther; 2018; 12():735-742. PubMed ID: 29670330
[TBL] [Abstract][Full Text] [Related]
18. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
Snehalatha C; Ramachandran A; Satyavani K; Latha E; Viswanathan V
Diabetes Care; 1998 Jan; 21(1):76-9. PubMed ID: 9538973
[TBL] [Abstract][Full Text] [Related]
19. Effect of aerobic exercise combined with ginkgo polysaccharide on weight, blood glucose and glycosylated serum protein in diabetic rats.
Zhu R; Xie J
Pak J Pharm Sci; 2018 May; 31(3(Supplementary)):1045-1050. PubMed ID: 29731442
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of Ginkgo biloba extract on insulin signaling cascade, dyslipidemia, and body adiposity of diet-induced obese rats.
Banin RM; Hirata BK; Andrade IS; Zemdegs JC; Clemente AP; Dornellas AP; Boldarine VT; Estadella D; Albuquerque KT; Oyama LM; Ribeiro EB; Telles MM
Braz J Med Biol Res; 2014 Sep; 47(9):780-8. PubMed ID: 25075573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
